Goldman Sachs Group Inc Karyopharm Therapeutics Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,336,715 shares of KPTI stock, worth $962,434. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,336,715
Previous 2,290,434 41.64%
Holding current value
$962,434
Previous $1.99 Million 44.33%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$0.7 - $1.06 $667,603 - $1.01 Million
-953,719 Reduced 41.64%
1,336,715 $1.11 Million
Q2 2024

Aug 13, 2024
BUY
$0.87 - $1.58 $680,489 - $1.24 Million
782,172 Added 51.86%
2,290,434 $1.99 Million
Q1 2024

May 15, 2024
BUY
$0.72 - $1.66 $152,401 - $351,370
211,669 Added 16.33%
1,508,262 $2.28 Million
Q4 2023

Feb 13, 2024
SELL
$0.68 - $1.31 $420,548 - $810,174
-618,454 Reduced 32.29%
1,296,593 $1.12 Million
Q3 2023

May 14, 2024
BUY
$1.14 - $1.81 $705,037 - $1.12 Million
618,454 Added 47.7%
1,915,047 $2.57 Million
Q3 2023

Nov 14, 2023
BUY
$1.14 - $1.81 $335,191 - $532,190
294,028 Added 18.14%
1,915,047 $2.57 Million
Q2 2023

May 14, 2024
BUY
$1.79 - $4.59 $271,850 - $697,092
151,872 Added 10.34%
1,621,019 $2.9 Million
Q2 2023

Aug 14, 2023
BUY
$1.79 - $4.59 $271,850 - $697,092
151,872 Added 10.34%
1,621,019 $2.9 Million
Q1 2023

May 14, 2024
BUY
$2.84 - $3.92 $1.17 Million - $1.62 Million
412,514 Added 39.04%
1,469,147 $5.71 Million
Q1 2023

May 11, 2023
BUY
$2.84 - $3.92 $1.17 Million - $1.62 Million
412,514 Added 39.04%
1,469,147 $5.71 Million
Q4 2022

May 14, 2024
SELL
$2.48 - $5.93 $740,386 - $1.77 Million
-298,543 Reduced 22.03%
1,056,633 $3.59 Million
Q4 2022

Feb 13, 2023
SELL
$2.48 - $5.93 $740,386 - $1.77 Million
-298,543 Reduced 22.03%
1,056,633 $3.59 Million
Q3 2022

May 14, 2024
SELL
$4.08 - $5.82 $372,202 - $530,935
-91,226 Reduced 6.31%
1,355,176 $7.4 Million
Q3 2022

Nov 10, 2022
SELL
$4.08 - $5.82 $372,202 - $530,935
-91,226 Reduced 6.31%
1,355,176 $7.4 Million
Q2 2022

May 14, 2024
BUY
$4.15 - $8.37 $621,707 - $1.25 Million
149,809 Added 11.55%
1,446,402 $6.52 Million
Q2 2022

Aug 15, 2022
BUY
$4.15 - $8.37 $2.27 Million - $4.58 Million
547,496 Added 60.91%
1,446,402 $6.52 Million
Q1 2022

May 16, 2022
SELL
$5.91 - $14.38 $768,158 - $1.87 Million
-129,976 Reduced 12.63%
898,906 $6.63 Million
Q4 2021

Feb 14, 2022
BUY
$5.21 - $8.61 $226,635 - $374,535
43,500 Added 4.41%
1,028,882 $6.62 Million
Q3 2021

Nov 10, 2021
BUY
$4.45 - $10.63 $4.38 Million - $10.5 Million
985,382 New
985,382 $5.74 Million

Others Institutions Holding KPTI

# of Institutions
98
Shares Held
57.6M
Call Options Held
258K
Put Options Held
81.2K
View Full List

About Karyopharm Therapeutics Inc.

KPTI Quotes by TradingView
  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $57.5M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email